Updated
June 22, 2023
If you developed an eye infection after using recalled Delsam Pharma artificial tears, you may be able to pursue a claim for your injuries.
Delsam Pharma Artificial Tears Linked to Infections
Claims are being investigated that Delsam Care Artificial Tears Lubricant Eye Drops caused eye infections in people who used them. Delsam Care is sold over the counter to relieve dry and irritated eyes. Recently, there have been a significant number of cases where people developed antibiotic-resistant eye infections following use of artificial tears. Some infections became so severe they led to permanent vision loss, hospitalization and even death when an infection got into the bloodstream.
Status
Investigation Ongoing
Nationwide recall issued Feb 2023
Claim Deadline
Open Intake
Estimated Payout
Varies
Proof Required
Yes
According to the CDC and the FDA, some of these specific Delsam tear drop products are liable to lead to serious consumer injuries that might include some of the following:
• Severe Eye Damage,
• Vision Loss,
• Serious Bacterial Infections,
• Death.
As part of the recall investigations and announcements, Delsam has taken every possible step in order to notify consumers of the serious potential consequences of continuing use of the Delsam eye drops. Possible symptoms of infection from Delsam eye drops can be:
• Eye pain or discomfort,
• Headaches,
• Vision problems.
The FDA recall website urges consumers to reach out via the Delsam eye drops recall information hotline listed on the FDA recall notice. Health care professionals are being encouraged to report any quality issues with these eye drops, as well as any adverse effects to patients and consumers by reaching out to the FDA. The FDA has an online reporting system for medical recalls such as the Delsam eye drop consumer recall, called MedWatch. Consumers can also reach out and report negative interactions with Delsam using the FDA consumer complaint site.
Additionally, the CDC has issued a warning that Delsam Pharma eye drops and eye ointments were reported to contain a certain strain of anti-biotic resistant bacteria. The CDC conducted extensive lab tests, which successfully identified the presence of this bacteria, known as "VIM-GES-CRPA" in certain bottles of Delsam Pharma artificial tear products, from several different batches of products. The bottles were received from consumers with and without eye infections after having consumed the Delsam Pharma dry eye products.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
For more open class actions keep scrolling below.
